SOCS1-based therapies mitigate vascular and renal oxidative stress in diabetic mice through STAT1-and PI3K-dependent mechanisms. (August 2018) - López Sanz, L.; Bernal, S.; Lazaro, I.; Jimenez Castilla, L.; Melgar, A.; Egido, J.; Gomez Guerrero, C.